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3 epithelial-mesenchymal transition (EMT), a critical process of tubulointerstitial fibrosis (TIF), is also driven by TGF-β1 47 5, 6 . Smad is a significant downstream gene of TGF-β1 in the fibrogenesis. TGF-β1 leads to fibrogenic effect by the 48 upregulation of Smad2 and Smad3 expression and the downregulation of Smad7 expression.
49
Renin-angiotensin system (RAS) and Wnt/β-catenin pathways also play an important role in renal fibrosis 7, 8 . All of the
50
RAS components are present in the kidney tissues and activation of intrarenal RAS is a key component in the 51 development and progression of renal fibrosis 9 . RAS consists of angiotensinogen (ATG), renin, angiotensin-converting 52 enzyme (ACE), angiotensin II (Ang II), angiotensin II type 1 receptor (AT1) and angiotensin II type 2 receptor (AT2).
53
Ang II is a key mediator in RAS-induced renal fibrosis. It stimulates TGF-β1 expression in the kidney, or directly
54
phosphorylates Smad2 and Smad3 to promote fibrosis [10] [11] [12] . Although silent in adult kidney, Wnt/β-catenin is reactive 55 after kidney injury. Wnt/β-catenin signaling induces renal fibrosis through promoting downstream target genes 56 expression, most of which are fibrosis-related genes, including snail, twist, fibronectin, matrix metalloproteinase-7
57
(MMP-7), fibroblast specific protein-1 (Fsp-1), plasminogen activator inhibitor-1 (PAI-1) and RAS components
13
.
58
Targeting inhibition of RAS/Wnt/β-catenin axis achieved better anti-fibrotic effect than targeting a single pathway,
59
which indicated a new therapeutic strategy to mitigate renal fibrosis 8 .
60
Recent studies demonstrated that small molecular weight natural products exhibited a good therapeutic effect on renal 61 fibrosis [14] [15] [16] [17] [18] [19] . Our previous studies showed that the ethanol extract of the surface layer of Poria cocos (SLPC) enhanced 62 diuresis and was highly effective in the treatments of CKD 20, 21 . Further investigation indicated that the ethyl acetate 63 extract of SLPC exhibited processes remarkable diuretic and anti-fibrotic effects [22] [23] [24] [25] . In the present study, we 64 investigated the renoprotective effect of three compounds with different skeletons isolated from the ethyl acetate extract 6 were transfected with 3µl of 10 µM siRNA/well. Lipofectamine RNAiMAX was employed. 
126
USA). Membranes were blocked in 1×TBS with 0.1% Tween-20 (TBST) with 5% non-fat milk and then were 127 incubated with the primary antibodies. Finally, membranes were washed, incubated with goat anti-rabbit (1:5000, 128 ab6721, Abcam, USA), goat anti-mouse (1:5000, A21010, Abbkine, USA) or rabbit anti-goat (1:5000, A21110,
129
Abbkine, USA) secondary antibodies, and developed with ECL (RPN2232, GE Healthcare, USA).
130
The following primary antibodies were employed (dilution): AGT ( 
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C-15, C-16 and C-17, respectively. A chain structure from C-1' to C-9' connected with C-18 was confirmed by the 169 important connectivities found in the heteronuclear multiple-bond connectivity (HMBC) spectrum (as shown in Figure ( 149.7, 142.3, 138.0, 120.8, 118.4 and 112.6 , and one oxymethine carbon at δ C 76.8. 
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We investigated the inhibitory effect of PZF, PZG and PZH on ECM accumulation, which was mainly expressed by 
255
whereas PZF showed a weak regulatory effect on this abnormality (Figure 3G,H explain the results that once Smad3 decreased, PZG and PZH lost the intervention target and thus showed no effect on 301 renal fibrosis. First, we examined the inhibitory effect of specific Smad3 siRNA, founding that the protein expression of
302
Smad3 was significantly downregulated in HK-2 cells induced by specific Smad3 siRNA ( Figure 7A) . Moreover, PZF,
303
PZG and PZH had no influence on the process of RNAi, and would not upregulate Smad3 protein expression ( Figure   304 7B). Interestingly, after knockdown Smad3, the anti-fibrosis of PZG and PZH significantly weakened, which provided 305 the evidence that Smad3 was the main intervention target of PZG and PZH to mitigate renal fibrosis ( Figure 7C,D) . 
329
However, PZF showed a weak effect, indicating triterpene components were the active component of SLPC, instead of 330 diterpene components. These important bioactivities may be associated with the first six-membered ring and the number 331 of carboxyl groups in secolanostane and lanostane tetracyclic triterpenoid compounds. This study provided activity 332 targets for anti-fibrosis drug research and development.
333
Regardless of the type of initial injury to the kidney, renal fibrosis is the common final pathway of CKD to ESRD 39 .
334
The 
384
In this study, we isolated the active components of renoprotective effect of SLPC and elucidated their anti-fibrotic 
